RankingsPricing
  1. US-listed companies
  2. CRISPR Therapeutics AG
  3. Financials
  4. Pretax margin (%)

CRISPR Therapeutics AGCRSP

Market cap
$4.8B
P/E ratio
SummaryFinancials
Period EndPretax margin (%) YoY (%)
Dec 31, 2024-971.9+2293.71%
Dec 31, 2023-40.6-99.93%
Dec 31, 2022-54,298.8-131002.14%
Dec 31, 202141.5-100.09%
Dec 31, 2020-48,408.3-208381.17%
Dec 31, 201923.2-100.44%
Dec 31, 2018-5,263.4+3139.59%
Dec 31, 2017-162.5-63.07%
Dec 31, 2016-439.9

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)